Levetiracetam Krka

Levetiracetam, the active ingredient in Levetiracetam Krka, is an anticonvulsant presented as an oral tablet for oral use. It treats partial, generalized tonic‑clonic and myoclonic seizures in patients with epilepsy. GNH USA supplies Levetiracetam Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug used to control various seizure types.

Partial seizures: reduces frequency and severity of focal onset seizures. Generalized tonic‑clonic seizures: helps prevent convulsive episodes. Myoclonic seizures: diminishes rapid, involuntary muscle jerks associated with myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dizziness: sensation of light‑headedness or loss of balance. - Headache: mild to moderate cranial pain. - Irritability: increased mood swings or agitation. - Nausea: upset stomach or urge to vomit. - Nasal congestion: blocked or runny nose.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood changes: depression, suicidal thoughts, or aggressive behavior. - Blood disorders: low white blood cells or platelets. - Liver dysfunction: jaundice or abnormal liver enzymes. - Skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before initiating therapy, consider the following precautions.

Renal function: dose may need adjustment in patients with impaired kidney function. Pregnancy: safety data are limited; discuss risks with a healthcare professional. Psychiatric history: monitor for mood changes or suicidal ideation. Concomitant CNS depressants: may increase sedation or dizziness. Alcohol use: can enhance central nervous system effects. Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Levetiracetam can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: can lower levetiracetam concentrations. - Phenytoin: may decrease levetiracetam exposure.

Moderate Interactions (Monitor Closely): - Oral contraceptives: levetiracetam may reduce hormonal efficacy. - Sedatives or hypnotics: increased risk of drowsiness. - Antidepressants: potential for heightened mood alterations.